Department Of Internal Medicine 10
451. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
452. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
453. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
454. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
455. Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
456. Occupational Burden of Chronic Obstructive Pulmonary Disease in the Commonwealth of Independent States: Systematic Review and Meta-Analysis
457. Occupational Burden of Chronic Obstructive Pulmonary Disease in the Commonwealth of Independent States: Systematic Review and Meta-Analysis
458. Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in Kazakhstan in a Nationwide Population-Based Epidemiological Study
459. Apoptotic cell death in disease—Current understanding of the NCCD 2023
460. Divergent Cardiac Adaptations in Endurance Sport: Atrial Fibrillation Markers in Marathon Versus Ultramarathon Athletes
461. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
462. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
463. Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
464. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
465. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
466. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
467. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
468. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
469. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
470. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
471. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
472. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
473. Impact of COVID-19 on the Risk of Coronary Stent Thrombosis and Restenosis: A Retrospective Angiographic Study
474. Prevalence and Molecular Characterization of Moniezia Species in Ruminants Based on ITS1-5.8S rRNA from Van Province, Turkey
475. Systemic Sclerosis with Interstitial Lung Disease: Identification of Novel Immunogenetic Markers and Ethnic Specificity in Kazakh Patients
476. Comparison of morrow procedure and transapical beating-heart septal myectomy in patients with hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis
477. The Assessment of the Nutritional Status among the Young-Old and Old-Old Population with Alimentary-Dependent Diseases
478. Epstein–Barr virus-induced gene 3 commits human mesenchymal stem cells to differentiate into chondrocytes via endoplasmic reticulum stress sensor
479. Global burden of metabolic diseases, 1990–2021
480. Global burden of metabolic diseases, 1990–2021
481. mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitors
482. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
483. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021 (eClinicalMedicine (2024) 76, (S2589537024004279), (10.1016/j.eclinm.2024.102848))
484. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
485. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
486. Camel Milk-Based Fermented Product “Inullact-Fito” Ameliorates Metabolic and Immunological Disturbances in Alloxan-Induced Diabetes
487. Klotho: Potential Marker of High Cardiovascular Risk in Patients With Acute Coronary Syndrome and Chronic Kidney Disease
488. Global practice guidelines in rheumatology: a cross-sectional altmetric and citation analysis
489. Varicose veins and venous thromboembolism in inflammatory rheumatic diseases: vascular complications and rehabilitation approaches
490. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
491. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
492. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
493. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
494. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
495. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
496. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
497. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
1 8 9 10 10